LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Status of cardio‐oncology in Australia in 2021: a nationwide multidisciplinary survey

Photo from wikipedia

Cardio-oncology is a growing subspeciality globally, owing to the success of cancer therapies with improved survival, to the extent that cardiovascular mortality is now the leading cause of death in… Click to show full abstract

Cardio-oncology is a growing subspeciality globally, owing to the success of cancer therapies with improved survival, to the extent that cardiovascular mortality is now the leading cause of death in long-term survivors. Cardio-oncology services involve the prevention, identification and treatment of cardiovascular complications amongst cancer patients and survivors. No data are available on the current set-up and availability of cardio-oncology services in Australia. We performed an anonymous online national survey of cardio-oncology stakeholders, including medical/ radiation oncologists, haematologists and cardiologists. The survey was approved by the local Ethics Committee (HREA/2021/ETH00083) and distributed through relevant speciality societies’ (i.e. Clinical Oncology Society of Australia, Haematology and Cardiac Societies of Australia and New Zealand) membership mailing lists and electronic newsletters after each societies’ governance approval. Additionally, we advertised the survey on Twitter (California, USA). After excluding four responses (incomplete response, n = 1; non-cardio-oncology specialties, n = 3), 118 responses throughout Australia were analysed (Fig. 1A). Most participants were medical oncologists (35%; Fig. 1B) and 86% agreed or strongly agreed the importance as a subspeciality (Fig. 1C). Most (70%) institutions did not have dedicated cardio-oncology services, mainly due to insufficient funding (48%), and lack of expertise (30%), where the cardiooncology patients were often seen in general cardiology. The majority (78%) were planning to commence their cardio-oncology services in the next 2 years. The main reason for not planning to set up a service was insufficient funding (54%). Increased cardio-oncology sessions at national society meetings were supported by 88% of responses and 97% supported having national cardiooncology guidelines (Fig. 1D). Overall, cancer and haematology specialists estimated 15% (interquartile range 10–26) of their patients did not receive optimal cancer treatment because of cardiotoxicity

Keywords: cancer; survey; oncology services; oncology; cardio oncology

Journal Title: Internal Medicine Journal
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.